Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Pharmaceutical Research|May 16, 2020
An Integrated Dialysis Pharmacometric (IDP) Model to Evaluate the Pharmacokinetics in Patients Undergoing Renal Replacement TherapyAstrid Broeker, Matthias G Vossen, Florian Thalhammer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2018
Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of ViennaSelma Tobudic, Christina Forstner, Heinz Burgmann, et al.
Antibiotics (Basel, Switzerland)|April 27, 2026
Real-World Experience on the Use of Eravacycline at Doses of 1 mg/kg Bodyweight and Fixed Dose Strategy in Two European Tertiary CentersKarin Oberreiter, Miriam M Moser, Lisa Schneider, et al.
Wiener Klinische Wochenschrift|December 6, 2007
[In vitro interaction studies of azithromycin and dihydroartemisinin in Plasmodium falciparum isolates from Bangladesh]Matthias G Vossen, Rashidul Haque, Peter Starzengruber, et al.
Frontiers in Pharmacology|May 28, 2021
Synergistic Effect of Cefazolin Plus Fosfomycin Against Staphylococcus aureus in vitro and in vivo in an Experimental Galleria mellonella ModelManuel Kussmann, Markus Obermueller, Matthias Karer, et al.
Wiener Klinische Wochenschrift|January 1, 2007
In vitro interaction of dihydroartemisin and lumefantrine in clinical field isolates from BangladeshKamala Thriemer, Wasif Ali Khan, Peter Starzengruber, et al.
The Journal of Infectious Diseases|June 19, 2010
Azithromycin combination therapy for the treatment of uncomplicated falciparum malaria in Bangladesh: an open-label randomized, controlled clinical trialKamala Thriemer, Peter Starzengruber, Wasif Ali Khan, et al.
Annals of Intensive Care|January 17, 2025
Renin-angiotensin-aldosterone system activation in plasma as marker for prognosis in critically ill patients with COVID-19: a prospective exploratory studyKatharina Krenn, Felix Kraft, Luana Mandroiu, et al.
The Journal of Antimicrobial Chemotherapy|November 26, 2022
Comparison of ultrafiltration and microdialysis for ceftriaxone protein-binding determinationMaria Sanz-Codina, Sebastian G Wicha, Beatrix Wulkersdorfer, et al.
Journal of Clinical Microbiology|December 23, 2011
Gemella morbillorum bacteremia after anti-tumor necrosis factor alpha as acne inversa therapyMatthias G Vossen, Klaus B Gattringer, Neda Khalifeh, et al.
Pageof 3